GENE ONLINE|News &
Opinion
Blog

Cardiovascular
J&J’s Q2 Increase: Cardiovascular Gains and Strategic Moves Amid Vaccine Decline
2024-08-06
Shanghai’s Hasten Seals $322 Million Acquisition of Takeda Drugs
2022-04-06
GeneOnline’s Top 10 M&As of 2021
2022-01-11
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
LATEST
EY Predicts Smarter, Smaller M&A in Biotech and Pharma for 2025
2025-01-15
Asia Microbiome Conference Reached a New Milestone: From Innovative Forum to Microbiome Carnival
2025-01-15
The Impact of “Inner Excellence” on A.J. Brown’s Performance and Mindset
2025-01-14
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
2025-01-10
United Imaging Announces Major Expansion of U.S. Manufacturing Space
2025-01-09
Posdinemab Becomes J&J’s Second FDA Fast Track Designation Targeting Phosphorylated Tau in Alzheimer’s Disease
2025-01-09
Key Market Trends Shaping Health Systems and Specialty Pharmacies
2025-01-08
EVENT
2025-01-13
Biotech Showcase 2025
San Francisco, California
2025-01-13
JP Morgan Healthcare Conference
San Francisco, California
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
Scroll to Top